Pfizer Fellowship Grant RFP Transthyretin Cardiac Amyloidosis Fellowship

Organization
Pfizer
Type
Foundation
Application Due Date
06-20-2023
Brief Description

This competitive program seeks to promote the importance of training physicians to recognize and diagnose cardiac ATTR amyloidosis and to foster research in the field of transthyretin cardiac amyloidosis.

Geographic Scope United States

Project Types and Area of Interest It is our intent to support institutions with fellowship programs for Cardiologists that have a strong focus on clinical practice, research, and education to further the understanding of transthyretin cardiac amyloidosis